Re­lay grabs $63M to pay for a drug dis­cov­ery trip in­to the fourth di­men­sion

Two years af­ter Third Rock launched Re­lay Ther­a­peu­tics to ex­plore the drug dis­cov­ery po­ten­tial of watch­ing pro­teins in mo­tion, the Cam­bridge, MA-based biotech is back with a $63 mil­lion round to pay for the next leg of the jour­ney to­ward the clin­ic.

San­jiv Pa­tel joined Re­lay last April from his job as chief strat­e­gy of­fi­cer at Al­ler­gan, tak­ing over from Third Rock part­ner Alex­is Borisy. Now he’s in charge of a group of 43 staffers in­volved in some­thing he feels is com­plete­ly unique.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER